IDEXX Laboratories, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 968.38 M

IDEXX Laboratories, Inc. Operating Cash Flow is USD 968.38 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 5.12% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • IDEXX Laboratories, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 921.18 M, a 50.47% change year over year.
  • IDEXX Laboratories, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 612.19 M, a -17.92% change year over year.
  • IDEXX Laboratories, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 745.83 M, a 0.16% change year over year.
  • IDEXX Laboratories, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 744.61 M, a 64.50% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities